Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
Mol Immunol. 2011 Jan;48(4):637-46. doi: 10.1016/j.molimm.2010.11.001. Epub 2010 Nov 27.
Aerosolized fish proteins are an important cause of allergic airway reactions in both the domestic and the occupational environment. The aim of this study was to investigate inhalant fish-induced allergy in a mouse model and compare immune responses generated by raw and heat-treated fish extracts as well as natural and recombinant forms of the major fish allergen parvalbumin. Mice were sensitized with raw or cooked pilchard extract and challenged intranasally with cooked pilchard extract, purified natural pilchard parvalbumin or recombinant carp parvalbumin (rCyp c1.01). Cooked pilchard extract predominantly sensitized mice to parvalbumin and induced specific IgG1 and IgE antibodies against both pilchard parvalbumin and rCyp c1.01, whereas additional allergens were recognized by mice sensitized with raw extract, including a 36 kDa allergen that was also recognized by fish processing workers and was identified as glyceraldehyde-3-phosphate dehydrogenase. Mice challenged with cooked extract and purified pilchard parvalbumin had increased Th2 cytokine production in mediastinal lymph node cells and splenocytes, whereas mice challenged with rCyp c1.01 did not. This study identifies a new IgE-binding protein that may be important in occupational allergy to fish and demonstrates the feasibility of testing recombinant allergens for immunotherapeutic potential in vivo.
雾化的鱼类蛋白是诱发家庭和职业环境中气道过敏反应的重要原因。本研究旨在建立鱼类吸入性过敏的小鼠模型,比较生的和热加工的鱼类提取物、天然及重组形式的主要鱼类过敏原副肌球蛋白的免疫应答。用生的或熟的沙丁鱼提取物致敏小鼠,然后用熟的沙丁鱼提取物、天然的沙丁鱼副肌球蛋白或重组鲤鱼副肌球蛋白(rCyp c1.01)经鼻内激发。熟的沙丁鱼提取物主要使小鼠致敏副肌球蛋白,并诱导针对沙丁鱼副肌球蛋白和 rCyp c1.01 的特异性 IgG1 和 IgE 抗体,而用生的提取物致敏的小鼠还识别其它过敏原,包括一种 36 kDa 的过敏原,该过敏原也被鱼类加工工人识别,被鉴定为甘油醛-3-磷酸脱氢酶。用熟的提取物和纯化的沙丁鱼副肌球蛋白激发的小鼠,其胸内淋巴结细胞和脾细胞中 Th2 细胞因子的产生增加,而用 rCyp c1.01 激发的小鼠则没有。本研究鉴定了一种新的 IgE 结合蛋白,它可能在鱼类职业性过敏中起重要作用,并证实了用重组过敏原进行体内免疫治疗潜力测试的可行性。